Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D5T6DY
|
|||
Drug Name |
AMG 404
|
|||
Drug Type |
Antibody
|
|||
Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C00-D48; ICD-9: 140-199] | Phase 1 | [1] | |
Company |
Amgen
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Programmed cell death protein 1 (PD-1) | Target Info | Inhibitor | [1] |
KEGG Pathway | Cell adhesion molecules (CAMs) | |||
T cell receptor signaling pathway | ||||
Reactome | PD-1 signaling | |||
WikiPathways | T-Cell Receptor and Co-stimulatory Signaling | |||
Costimulation by the CD28 family |
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT03853109) AMG 404 in Patients With Advanced Solid Tumors.. U.S. National Institutes of Health. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.